about
Clinical use and applications of histone deacetylase inhibitors in multiple myelomaMicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerMicroRNAs in B-cells: from normal differentiation to treatment of malignanciesDrug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Novel therapeutic strategies for multiple myelomaValidating reference microRNAs for normalizing qRT-PCR data in bovine oocytes and preimplantation embryos.Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapyLow serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myelomaIdentification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.The role of epigenetics in the biology of multiple myeloma.Mir-34: a new weapon against cancer?Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development.Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.Microenvironment drug resistance in multiple myeloma: emerging new players.Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells.MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.MicroRNA expression patterns in medullary and extramedullary plasmacytoma.MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer.Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia
P2860
Q26745930-B61AC8FB-BD38-40BA-9BE0-92F9998F809CQ26777313-77116469-D9C3-4E50-9593-AEE9D241888BQ26824682-3BC9C326-4A8A-4299-9662-5A14FE88EA44Q27692033-2F4F008F-CA82-46ED-861C-68FD9AE6DAECQ28081590-6FB1EDE9-0D7D-479C-8960-408F96879896Q30969414-E57B31BC-F3F2-4AC3-8851-76461CA91387Q34287900-35B3D7BA-D96A-4C9F-960F-1E0A23960935Q35246395-BBFD9420-D2A9-4A82-AEDE-2AA4F3869A5AQ36803165-BCCBE6F2-7357-4F38-82E7-830CC98EF4ABQ37373624-D4E36677-5433-4887-BD77-EB435983EE44Q37597751-46E80DC9-3BE5-4E86-9817-0D768A968B24Q38208520-34F1AE1A-97B3-4DEF-84D1-ED0CC59FD398Q38253374-80B84694-AE2D-4723-9FA0-C19D0396D799Q38348173-15E743FE-8F28-4EFA-928D-6AF6E24758E2Q38435781-D0018740-444D-446A-9F29-9474A7159B7FQ38823802-AA963100-9175-49CE-9C29-FA8236424094Q38868804-35C1FBDE-C18E-4D78-B4A0-63EFB78E5B91Q38913083-5C22552B-7DF2-4087-B89D-3A1B44D7CF82Q38960149-D0CB5FCF-0963-464F-B425-A30E0310EFF3Q39255792-99981466-0093-4876-8E86-4EE0D46C7F7CQ39379624-90B5E8EE-544B-4AB0-9830-6751E315D72CQ42566009-D8DDC6E7-A341-4358-BBAA-1A3EA5327938Q42719013-2D5E90D4-0519-4F80-870C-3DB4CBB4E207Q50017249-338685AE-E883-4B69-A210-8065F330755EQ58699070-E10BA9BD-A44C-447E-84BF-EADC474E9B2A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aberrant microRNA expression in multiple myeloma.
@en
type
label
Aberrant microRNA expression in multiple myeloma.
@en
prefLabel
Aberrant microRNA expression in multiple myeloma.
@en
P2093
P2860
P356
P1476
Aberrant microRNA expression in multiple myeloma.
@en
P2093
Kirsten Grønbæk
Konstantinos Dimopoulos
Peter Gimsing
P2860
P304
P356
10.1111/EJH.12124
P577
2013-06-05T00:00:00Z